# SGMO (Sangamo Therapeutics, Inc.) - SEC EDGAR Financial Statements

> Sangamo Therapeutics, Inc. reported $34.56M in revenue and a net loss of $123.3M for the trailing twelve months ended March 31, 2026 (down 77.6% year over year), with a -357.5% operating margin.

- Canonical: https://convexityos.com/fundamentals/SGMO
- Markdown: https://convexityos.com/fundamentals/SGMO.md
- SEC CIK: 0001001233
- Reporting currency: USD
- Latest filing period: March 31, 2026
- Last synced: Nov 20, 2026, 05:53 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001001233&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $34.56M | -77.6% YoY |
| Operating Income | TTM | -$123.6M | -357.5% margin |
| Net Income | TTM | -$123.3M | -356.9% net margin |
| Diluted EPS | TTM | -$0.32 | Split-adjusted |
| Free Cash Flow | TTM | -$90.46M | -261.8% FCF margin |
| Cash & ST Investments | Mar 31, 2026 | $27.59M | Total debt: $19.33M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $39.55M | $57.80M | $176.2M | $111.3M | $110.7M | $118.2M | $102.4M | $84.45M | $36.57M | $19.39M |
| Research & Development | $112.7M | $111.5M | $234.1M | $249.9M | $230.8M | $180.6M | $145.9M | $114.9M | $65.73M | $65.62M |
| Total Operating Expenses | $160.8M | $161.8M | $450.2M | $312.6M | $294.0M | $247.7M | $207.6M | $161.6M | $92.93M | $91.95M |
| **Operating Income** | -$121.2M | -$104.0M | -$274.0M | -$201.3M | -$183.3M | -$129.6M | -$105.2M | -$77.15M | -$56.36M | -$72.56M |
| **EBITDA** | -$117.3M | -$98.86M | -$258.9M | -$189.2M | -$173.9M | -$123.9M | -$101.2M | -$74.79M | -$54.86M | -$71.56M |
| Interest Income | $1.30M | $1.51M | -- | -- | -- | -- | -- | -- | -- | -- |
| Income Before Tax | -$123.5M | -$98.11M | -$262.9M | -$191.8M | -$178.0M | -$120.8M | -$95.42M | -$68.89M | -$54.57M | -$71.67M |
| Income Tax Expense | -$568K | -$167K | -$5.07M | $429K | $306K | $345K | $0 | $0 | $0 | -$14K |
| **Net Income** | -$122.9M | -$97.94M | -$257.8M | -$192.3M | -$178.3M | -$121.0M | -$95.19M | -$68.33M | -$54.57M | -$71.66M |
| Basic EPS | -$0.44 | -$0.49 | -$1.48 | -$1.25 | -$1.23 | -$0.90 | -$0.85 | -$0.70 | -$0.70 | -$1.02 |
| **Diluted EPS** | -$0.44 | -$0.49 | -$1.48 | -$1.25 | -$1.23 | -$0.90 | -$0.85 | -$0.70 | -$0.70 | -$1.02 |
| Basic Shares Outstanding | 280.2M | 201.7M | 174.4M | 154.3M | 144.6M | 134.4M | 112.1M | 96.9M | 78.1M | 70.6M |
| Diluted Shares Outstanding | 280.2M | 201.7M | 174.4M | 154.3M | 144.6M | 134.4M | 112.1M | 96.9M | 78.1M | 70.6M |

### Income Statement (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.44M | $14.23M | $581K | $18.31M | $6.44M | $7.55M | $49.41M | $356K |
| Research & Development | $26.57M | $31.44M | $28.14M | $27.08M | $26.01M | $23.68M | $27.73M | $24.22M |
| Total Operating Expenses | $33.39M | $52.43M | $36.13M | $36.16M | $36.06M | $33.54M | $38.78M | $37.44M |
| **Operating Income** | -$31.95M | -$38.20M | -$35.55M | -$17.86M | -$29.63M | -$25.99M | $10.63M | -$37.08M |
| **EBITDA** | -$31.23M | -$37.24M | -$34.56M | -$16.86M | -$28.61M | -$24.75M | $11.85M | -$35.84M |
| Income Before Tax | -$31.00M | -$37.97M | -$35.09M | -$19.96M | -$30.48M | -$23.82M | $10.76M | -$36.05M |
| Income Tax Expense | $0 | -$553K | -$161K | $27K | $119K | -$427K | $88K | $74K |
| **Net Income** | -$31.00M | -$37.42M | -$34.93M | -$19.99M | -$30.60M | -$23.40M | $10.67M | -$36.13M |
| Basic EPS | -$0.08 | -- | -$0.11 | -$0.08 | -$0.14 | -- | $0.05 | -$0.18 |
| **Diluted EPS** | -$0.08 | -- | -$0.11 | -$0.08 | -$0.14 | -- | $0.04 | -$0.18 |
| Basic Shares Outstanding | 389.6M | -- | 304.3M | 256.9M | 220.3M | -- | 208.3M | 203.9M |
| Diluted Shares Outstanding | 389.6M | -- | 304.3M | 256.9M | 220.3M | -- | 214.3M | 203.9M |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $20.95M | $41.92M | $45.20M | $100.4M | $178.9M | $131.3M | $80.43M | $140.4M | $49.83M | $22.06M |
| Short-Term Investments | -- | -- | -- | $177.2M | $197.7M | $510.1M | $282.0M | $259.7M | $193.5M | -- |
| **Cash & Short-Term Investments** | $20.95M | $41.92M | $81.00M | $307.5M | $376.5M | $641.4M | $362.5M | $400.1M | $243.3M | $22.06M |
| Accounts Receivable, Net | $371K | $526K | $923K | $3.68M | $6.01M | $5.22M | $36.91M | $4.67M | $3.34M | $4.97M |
| **Total Current Assets** | $35.83M | $51.69M | $94.33M | $300.3M | $398.8M | $659.7M | $405.5M | $410.5M | $248.4M | $149.6M |
| Property, Plant & Equipment, Net | $11.04M | $17.89M | $26.87M | $63.53M | $51.52M | $41.32M | $29.93M | $78.72M | $31.07M | $6.56M |
| Goodwill | -- | $0 | $0 | $37.55M | $39.70M | $42.80M | $39.27M | $40.04M | $1.58M | $1.58M |
| Intangible Assets | -- | $0 | $0 | $50.73M | $53.76M | $58.13M | $53.16M | $54.24M | $0 | -- |
| Long-Term Investments | -- | -- | -- | $29.84M | $88.17M | $50.53M | $21.83M | $0 | $1.01M | -- |
| Other Non-Current Assets | $871K | $879K | $1.26M | $17.02M | $15.32M | $13.56M | $9.07M | $3.36M | $1.18M | $169K |
| **Total Non-Current Assets** | $23.91M | $49.94M | $70.99M | $262.2M | $323.2M | $278.9M | $232.0M | $179.9M | $38.34M | $8.31M |
| **Total Assets** | $59.74M | $101.6M | $165.3M | $562.5M | $721.9M | $938.5M | $637.5M | $590.4M | $286.7M | $157.9M |
| Accounts Payable | $14.44M | $15.48M | $15.26M | $22.42M | $9.76M | $12.55M | $6.67M | $3.35M | $16K | $2.58M |
| Deferred Revenue (Current) | $899K | $7.56M | $0 | $51.78M | $85.71M | $91.64M | $38.71M | $47.56M | $28.34M | $4.14M |
| **Total Current Liabilities** | $42.47M | $45.80M | $47.73M | $111.7M | $127.9M | $143.5M | $69.87M | $78.51M | $44.86M | $13.29M |
| Deferred Revenue (Non-Current) | $5.87M | $5.87M | $0 | $109.4M | $166.8M | $245.0M | $81.43M | $108.3M | $29.24M | $4.46M |
| Other Non-Current Liabilities | $580K | $933K | $1.19M | $1.21M | $1.22M | $7.01M | $5.71M | $1.96M | -- | -- |
| **Total Non-Current Liabilities** | $31.55M | $33.06M | $34.70M | $155.8M | $218.7M | $297.6M | $134.9M | $144.6M | $53.98M | $8.40M |
| **Total Liabilities** | $74.01M | $78.86M | $82.43M | $267.6M | $346.6M | $441.2M | $204.8M | $223.1M | $98.84M | $21.70M |
| **Total Debt (incl. Leases)** | $26.80M | $30.57M | $38.10M | $43.11M | $48.08M | $42.09M | $44.41M | -- | -- | -- |
| Common Stock | $3.51M | $2.13M | $1.78M | $1.67M | $1.46M | $1.42M | $1.16M | $1.02M | $856K | $709K |
| Retained Earnings | -$1.63B | -$1.50B | -$1.41B | -$1.15B | -$956.3M | -$778.0M | -$657.0M | -$562.7M | -$495.5M | -$440.9M |
| Accumulated Other Comp. Income | -$1.46M | -$7.53M | -$4.59M | -$8.40M | -$3.99M | $5.42M | -$2.45M | -$1.44M | -$286K | $20K |
| **Total Stockholders' Equity** | -$14.27M | $22.77M | $82.89M | $295.0M | $375.3M | $498.2M | $432.6M | $366.5M | $187.9M | $136.2M |
| Total Equity | -$14.27M | $22.77M | $82.89M | $295.0M | $375.3M | $497.4M | $432.7M | $367.3M | $187.9M | $136.2M |

### Balance Sheet (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $27.59M | $20.95M | $29.62M | $38.34M | $25.18M | $41.92M | $39.20M | $27.79M |
| **Cash & Short-Term Investments** | $27.59M | $20.95M | $29.62M | $38.34M | $25.18M | $41.92M | $39.20M | $27.79M |
| Accounts Receivable, Net | $873K | $371K | $523K | $372K | $366K | $526K | $10.50M | $581K |
| **Total Current Assets** | $37.11M | $35.83M | $44.08M | $49.89M | $37.60M | $51.69M | $58.13M | $40.08M |
| Property, Plant & Equipment, Net | $10.32M | $11.04M | $14.79M | $15.73M | $16.88M | $17.89M | $19.15M | $20.62M |
| Goodwill | -- | -- | -- | -- | -- | $0 | -- | -- |
| Intangible Assets | -- | -- | -- | -- | -- | $0 | -- | -- |
| Other Non-Current Assets | $870K | $871K | $871K | $890K | $882K | $879K | -- | -- |
| **Total Non-Current Assets** | $22.85M | $23.91M | $44.57M | $47.66M | $48.57M | $49.94M | $53.13M | $52.94M |
| **Total Assets** | $59.97M | $59.74M | $88.64M | $97.56M | $86.17M | $101.6M | $111.3M | $93.01M |
| Accounts Payable | $19.31M | $14.44M | $15.56M | $10.74M | $18.20M | $15.48M | $19.79M | $17.59M |
| Deferred Revenue (Current) | $402K | $899K | $7.56M | $7.56M | $7.56M | $7.56M | $774K | -- |
| **Total Current Liabilities** | $53.13M | $42.47M | $50.12M | $47.66M | $49.56M | $45.80M | $43.16M | $39.01M |
| Deferred Revenue (Non-Current) | $5.87M | $5.87M | $5.87M | $5.87M | $5.87M | $5.87M | -- | -- |
| Other Non-Current Liabilities | $580K | $580K | $977K | $962K | $933K | $933K | $1.24M | $1.22M |
| **Total Non-Current Liabilities** | $25.79M | $31.55M | $32.27M | $30.30M | $31.70M | $33.06M | $28.97M | $30.32M |
| **Total Liabilities** | $78.92M | $74.01M | $82.40M | $77.96M | $81.26M | $78.86M | $72.13M | $69.32M |
| **Total Debt (incl. Leases)** | $19.33M | $26.80M | $25.42M | $23.46M | $24.88M | $30.57M | $27.73M | $29.10M |
| Common Stock | $4.14M | $3.51M | $3.22M | $2.73M | $2.25M | $2.13M | $2.09M | $2.08M |
| Retained Earnings | -$1.66B | -$1.63B | -$1.59B | -$1.55B | -$1.53B | -$1.50B | -$1.48B | -$1.49B |
| Accumulated Other Comp. Income | -$2.51M | -$1.46M | -$1.45M | -$1.46M | -$5.53M | -$7.53M | -$4.22M | -$5.88M |
| **Total Stockholders' Equity** | -$18.95M | -$14.27M | $6.24M | $19.60M | $4.91M | $22.77M | $39.13M | $23.69M |
| Total Equity | -$18.95M | -$14.27M | $6.24M | $19.60M | $4.91M | $22.77M | $39.13M | $23.69M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$122.9M | -$97.94M | -$257.8M | -$192.3M | -$178.3M | -$121.1M | -$95.42M | -$68.89M | -$54.57M | -$71.66M |
| Depreciation & Amortization | $3.96M | $5.11M | $15.06M | $12.11M | $9.44M | $5.68M | $3.93M | $2.36M | $1.50M | $997K |
| Stock-Based Compensation | $9.08M | $12.38M | $27.36M | $31.65M | $32.96M | $25.71M | $19.33M | $14.68M | $9.09M | $15.06M |
| Change in Receivables | $155K | $397K | $2.75M | $2.33M | -$789K | $31.68M | -$32.24M | -$1.33M | $1.63M | -$2.14M |
| **Operating Cash Flow** | -$97.21M | -$67.14M | -$224.8M | -$223.6M | -$233.3M | $169.9M | -$144.4M | $36.55M | $11.18M | -$65.88M |
| Capital Expenditure | -$102K | -$267K | -$21.16M | -$20.17M | -$23.28M | -$14.71M | -$20.68M | -$43.06M | -$3.75M | -$732K |
| **Free Cash Flow** | -$97.31M | -$67.41M | -$246.0M | -$243.8M | -$256.5M | $155.2M | -$165.1M | -$6.51M | $7.43M | -$66.61M |
| Acquisitions, Net | -- | -- | -- | -- | -- | $0 | $0 | -$75.65M | $0 | -- |
| Purchases of Investments | -- | $0 | -$59.55M | -$277.4M | -$338.2M | -$570.8M | -$443.7M | -$451.2M | -$252.3M | -$218.6M |
| **Investing Cash Flow** | -$102K | $37.52M | $153.5M | $59.28M | $248.2M | -$271.6M | -$59.80M | -$178.1M | -$77.40M | $18.12M |
| Common Stock Issued | $21.48M | $21.86M | $15.11M | -- | -- | $2.02M | $2.04M | $1.48M | $818K | $1.11M |
| **Financing Cash Flow** | $70.75M | $28.38M | $14.59M | $84.66M | $32.86M | $153.1M | $142.0M | $231.7M | $97.49M | $337K |
| **Net Change in Cash** | -$22.47M | -$3.29M | -$55.24M | -$78.43M | $47.54M | $50.90M | -$61.99M | $90.59M | $31.27M | -$47.42M |

### Cash Flow Statement (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$31.00M | -$37.42M | -$34.93M | -$19.99M | -$30.60M | -$23.40M | $10.67M | -$36.13M |
| Depreciation & Amortization | $719K | $959K | $989K | $993K | $1.02M | $1.24M | $1.22M | $1.24M |
| Stock-Based Compensation | $992K | $2.13M | $2.13M | $2.23M | $2.60M | $3.28M | $3.31M | $3.06M |
| Change in Receivables | -$502K | $152K | -$151K | -$6.0K | $160K | $9.97M | -$9.91M | $110K |
| **Operating Cash Flow** | -$19.28M | -$24.40M | -$28.50M | -$18.16M | -$26.15M | -$3.35M | $11.76M | -$26.88M |
| Capital Expenditure | -$13K | -$14K | -$64K | -$24K | $0 | -$152K | -$115K | $0 |
| **Free Cash Flow** | -$19.30M | -$24.42M | -$28.56M | -$18.18M | -$26.15M | -$3.50M | $11.64M | -$26.88M |
| Purchases of Investments | -- | -- | -- | -- | -- | $0 | $0 | $0 |
| **Investing Cash Flow** | -$13K | -$14K | -$64K | -$24K | $0 | $1.32M | $233K | $127K |
| Common Stock Issued | $23.35M | $0 | -$106K | $21.59M | $0 | -$65K | $0 | $21.92M |
| **Financing Cash Flow** | $26.70M | $14.80M | $19.20M | $28.61M | $8.13M | $6.99M | -$203K | -$533K |
| **Net Change in Cash** | $6.64M | -$9.58M | -$9.32M | $13.16M | -$16.74M | $2.72M | $12.91M | -$27.55M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -306.5% | -179.9% | -155.5% | -180.8% | -165.6% | -109.6% | -102.7% | -91.4% | -154.1% | -374.2% |
| **Net Profit Margin** | -310.8% | -169.4% | -146.3% | -172.8% | -161.1% | -102.4% | -92.9% | -80.9% | -149.2% | -369.6% |
| Return on Equity (ROE) | -- | -430.1% | -311.1% | -65.2% | -47.5% | -24.3% | -22.0% | -18.6% | -29.0% | -52.6% |
| Return on Assets (ROA) | -205.8% | -96.4% | -156.0% | -34.2% | -24.7% | -12.9% | -14.9% | -11.6% | -19.0% | -45.4% |
| Current Ratio | 0.84x | 1.13x | 1.98x | 2.69x | 3.12x | 4.60x | 5.80x | 5.23x | 5.54x | 11.25x |
| Quick Ratio | 0.50x | 0.93x | 1.72x | 2.79x | 2.99x | 4.50x | 5.72x | 5.16x | 5.50x | 2.03x |
| Debt to Equity | -- | 1.34x | 0.46x | 0.15x | 0.13x | 0.08x | 0.10x | -- | -- | -- |
| **Revenue Growth (YoY)** | -31.6% | -67.2% | +58.3% | +0.5% | -6.3% | +15.4% | +21.3% | +131.0% | +88.6% | -51.0% |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -237.3% | -- | -495.1% | +227.0% | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -265.3% | -- | -- | -187.7% | -- | -- |
| 5Y Revenue / Share Growth | -83.9% | -68.6% | +16.0% | +54.0% | +178.6% | +106.3% | +77.5% | +257.4% | +101.8% | +216.5% |
| 10Y Revenue / Share Growth | -66.9% | -44.3% | +314.5% | +210.7% | +781.8% | +349.0% | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -357.5% | -306.5% | -331.6% | -76.9% | -128.7% | -179.9% | -267.8% | -2094.0% |
| **Net Profit Margin** | -356.9% | -310.8% | -331.3% | -77.5% | -124.6% | -169.4% | -257.9% | -2033.7% |
| Return on Equity (ROE) | -- | -- | -1744.5% | -323.0% | -1619.4% | -430.1% | -344.6% | -1053.9% |
| Return on Assets (ROA) | -205.7% | -205.8% | -122.9% | -64.9% | -92.2% | -96.4% | -121.2% | -268.4% |
| Current Ratio | 0.70x | 0.84x | 0.88x | 1.05x | 0.76x | 1.13x | 1.35x | 1.03x |
| Quick Ratio | 0.54x | 0.50x | 0.60x | 0.81x | 0.52x | 0.93x | 1.15x | 0.73x |
| Debt to Equity | -- | -- | 4.07x | 1.20x | 5.07x | 1.34x | 0.71x | 1.23x |
| **Revenue Growth (YoY)** | -77.6% | +88.4% | -98.8% | +5042.1% | +1238.3% | +269.8% | +425.8% | -94.8% |
| Operating Income Growth (YoY) | -- | -- | -434.4% | -- | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -427.3% | -- | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -320.0% | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -342.4% | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -345.3% | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
